The largest database of trusted experimental protocols
Sourced in United States

The RmIL-5 is a lab equipment product designed for conducting research and analysis. It serves as a tool for researchers and scientists to study interleukin-5, a cytokine involved in various biological processes. The core function of the RmIL-5 is to enable the detection, quantification, and analysis of interleukin-5 levels in samples, supporting research and investigation in relevant fields.

Automatically generated - may contain errors

7 protocols using rmil 5

1

B Cell Switching and Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cells were isolated with the EasySep Mouse B cell isolation kit (STEMCELL Technologies, Canada) from splenocytes. To induce CSR from IgM to IgG1, B cells (5 × 105 to 1 × 106 cells/ml) were activated with LPS (25 μg/ml) from Escherichia coli O55:B5 (Sigma, St. Louis, MO) and rmIL-4 (10 ng/ml) at 37°C (5% CO2). For IgA switching, cells were activated with anti-CD40 (1 μg/ml, clone 1C10, BioLegend), rmIL-4 (10 ng/ml, Peprotech), rmIL-5 (10 ng/ml, Peprotech), and rhTGFβ1 (transforming growth factor β 1, 1 ng/ml). Media were composed of RPMI 1640 (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% FBS, 1× minimum essential medium (MEM) non-essential amino acids, 10 mM Hepes, 2 mM Glutamax, 1 mM sodium pyruvate, 55 μM 2-mercaptoethanol, and gentamicin (50 μg/ml) (all from Thermo Fisher Scientific, Waltham, MA, USA). To enhance CreERT2-mediated deletion, we cultured cells from CreERT2 mice in the presence of 1 μM 4-hydroxytamoxifen (Tocris). All cytokines used above were from PeproTech (Rocky Hill, NJ, USA).
+ Open protocol
+ Expand
2

Optimizing B Cell Class Switching

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cells were isolated with the EasySep Mouse B cell isolation kit (Stem Cell Technology, Canada) from total splenocytes. To induce CSR from IgM to IgG1 or IgE, B cells (5×105−1×106 cells/ mL) were activated with 1 μg/mL anti-CD40 clone 1C10, Biolegend) and rmIL-4 (10 ng/mL, Peprotech). For IgG3 and IgG2b switching, B cells were activated with 25 ug/mL of LPS from E. coli O55:B5 (Sigma, St. Louis, MO) and 10 ng/mL rmIL-4 at 37°C 5% CO 2. For IgA and IgG1 switching, B cells were activated with anti-CD40 (1 μg/mL, clone 1C10, Biolegend), rmIL-4 (10 ng/mL, Peprotech), rmIL-5 (10ng/mL, Peprotech), and rhTGFβ (1 ng/mL).
+ Open protocol
+ Expand
3

Generating Bone Marrow-Derived Eosinophils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow-derived eosinophils (BMDEs) were generated as described (25 (link)). Briefly, bone marrow cells were collected from the femur and tibia bones by crushing and red blood cells will be lysed with ACK lysis buffer (Sigma). Low-density bone marrow progenitors were separated by gradient centrifugation (Histopaque 1083, Sigma) of 1700 RPM for 30 minutes. Low density bone marrow cells were seeded at 5 X 105 cells/mL in 24 wells plate (BD Falcon) in media containing IMDM (Gibco) with 10% fetal bovine serum (HyClone), 1% penicillin-streptomycin (Biological industries), 2 mM glutamine (Gibco),50 μM β-mercaptoethanol (Sigma) and supplemented with 100 ng/mL stem-cell factor (SCF; PeproTech) and 100 ng/mL FLT3-Ligand (FLT3-L; PeproTech) from day 0 to day 4. On day 4, the media containing SCF, and FLT3-L replaced with media containing 10 ng/ml recombinant mouse interleukin-5 (rmIL-5; Peprotech) alone. Medium refreshing was done every 3 days from day 4 to 14 until eosinophil purity reached >85%. Purity was assessed by flow cytometry using CCR3 (R&D) and Siglec-F (BD Bioscience) as eosinophils markers.
+ Open protocol
+ Expand
4

Murine Bone Marrow-Derived Eosinophil Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrows from the femur and tibia of 6- to 8-week-old mice were flushed with PBS and processed into a single-cell suspension. After red blood cells were lysed with red blood cell lysis buffer, cells were resuspended in bone marrow medium [RPMI 1640 containing 20% FBS, 55 μM β-mercaptoethanol, 10 mM nonessential amino acids, 1 mM sodium pyruvate, penicillin (100 IU/ml), streptomycin (100 μg/ml), 2 mM glutamine, and 25 mM Hepes buffer] at a concentration of 1 × 106 cells/ml. Cells were stimulated with stem cell factor (SCF; 100 ng/ml) and fms-like tyrosine kinase 3 ligand (FLT3L; 100 ng/ml) (both from PeproTech, Rocky Hill, NJ) for 4 days. On day 4, the medium containing SCF and FLT3L was replaced with a medium containing only rmIL-5 (10 ng/ml; PeproTech, Rocky Hill, NJ). On day 8, cells were transferred to new flasks and maintained in fresh medium supplemented with rmIL-5. Half of the medium was replaced with fresh medium containing rmIL-5 every other day, and the cell concentration was adjusted each time to 1 × 106 cells/ml. On day 14, BMDEs were stimulated with mIFNγ (15 ng/ml) and mTNF (15 ng/ml) for 16 hours to activate cells. BMDE purity and viability were analyzed by flow cytometry.
+ Open protocol
+ Expand
5

Isolation and Culture of Mouse Bone Marrow Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BALB/c mice were sacrificed and their femurs were isolated. Femoral marrow was rinsed with RPMI 1640 medium (HyClone; GE Healthcare Life Sciences, Logan, UT, USA), supplemented with streptomycin and penicillin (HyClone), 20% fetal bovine serum (HyClone), Fms-related tyrosine kinase 3 ligand (FLT3-L; PeproTech, Inc., Rocky Hill, NJ, USA), stem cell factor (SCF; PeproTech, Inc.) and recombinant mouse IL-5 (rmIL-5; PeproTech, Inc.). A total of 107 cells/ml were incubated at 37°C in 5% CO2.
+ Open protocol
+ Expand
6

Eosinophil Differentiation and Cytokine Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow-derived eosinophils were cultured in Iscove's modified Dulbecco's medium (IMDM; Invitrogen) with 20% FBS (Invitrogen), 100 IU/mL penicillin and 10 mg/mL streptomycin, 2 mM glutamine, 25 mM HEPES, 1 × nonessential amino acids, 1 mM sodium pyruvate and 0.006‰ β-mercaptoethanol (Sigma-Aldrich, St. Louis, USA) supplemented with 100 ng/mL rmSCF (PeproTech) and 100 ng/mL recombinant murine FLT-3 ligand (rm-FLT3-L; PeproTech) from days 0 to 4. On day 4, the medium was replaced with medium containing 10 ng/mL rmIL-5 (PeproTech). The cells were provided with fresh medium supplemented with rmIL-5 every 3 days until to 14 days. A total of 1 × 10 6 bone marrow-derived eosinophils per group were treated with 5.0 μg/cm 2 PM2.5 for 48 h with or without 100 ng/mL ruxolitinib (InvivoGen, San Diego, USA). After 48 h, the cell supernatants were harvested. The concentrations of IL-1β, IL-5 and IL-13 in the supernatants were determined using ELISA.
+ Open protocol
+ Expand
7

Isolation of Bone Marrow Eosinophils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male WT and Ox40-/- mice were used to obtain bone marrow eosinophils. After treatment with erythrocyte lysis buffer to remove RBCs, bone marrow cells were used for culture and sorting of mature BM eosinophils. Unselected mouse bone marrow progenitors harvested from WT or Ox40–/– mice were cultured with recombinant mouse (rm)FLT3-L (100 ng/ml, 250-31L, PeproTech, USA) and rmSCF (100 ng/ml, 250-03, PeproTech) for 4 days, followed by culture with rmIL-5 (10 ng/ml, 215-15, PeproTech) alone thereafter for 4-6 days to generate bone marrow-derived eosinophils (bmEos) as previously described (22 (link)). On Days 8-10, cultured eosinophils were purified with a FACS Aria II cell sorter (BD Biosciences, CA, USA) using gating on 7AAD-Siglec-F+SSC-Ahi cells as previously described (22 (link)). For natural BM eosinophils, mature BM eosinophils were sorted as previously described (23 (link)). Briefly, B cells (anti-B220), T cells (anti-CD3), DCs (anti-CD11c), neutrophils and macrophages (anti-Gr-1) were depleted by MACS. Then, the remaining cells were incubated with anti-7AAD, anti-FcϵRIα, anti-Siglec-F, and anti-CD11b antibodies. Live mature eosinophils, gated as 7AAD-FcϵRIα-Siglec-F+CD11bint cells, were sorted with a FACS Aria II cell sorter.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!